Form 4 for XENE Xenon Pharmaceuticals Inc.
Accepted 2022-11-28 00:00:00 ET · period of report 2022-11-23 · accession 0001209191-22-058916 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2022-11-28 | 2022-11-23+ | XENE | PATOU GARY | Dir | S - Sale+OE | $34.55 | -3,994 | 23.6K | -14% | -$138.0K |
| D | 2022-11-28 | 2022-11-25 | XENE | PATOU GARY | Dir | F - Tax | $34.37 | -120 | 25.5K | -0.5% | -$4,124 |
| D | 2022-11-28 | 2022-11-25 | XENE | PATOU GARY | Dir | M - OptEx | $2.68 | +2,057 | 25.6K | +9% | +$5,513 |
| D | 2022-11-28 | 2022-11-25 | XENE | PATOU GARY | Dir | M - OptEx | $0.00 | -2,057 | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Shares | 2022-11-25 | S | D | 1,937 | $34.79 | 23,573 | D | — | — | (F4) The "Amount" and "Price" reported in this Column 4 reflect the aggregate number and weighted-average price, respectively, of shares sold. These shares were sold in multiple transactions at prices ranging from $34.76 to $34.90, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein. |
| 2 | Common | Common Shares | 2022-11-25 | F | D | 120 | $34.37 | 25,510 | D | — | — | (F3) Represents the closing price of the Company's common shares on November 23, 2022 for purposes of net settlement calculations. |
| 3 | Common | Common Shares | 2022-11-25 | M | A | 2,057 | $2.68 | 25,630 | D | — | — | (F2) The exercise price was converted to U.S. dollars from $2.67 CAD using the closing rate of exchange on the Bank of Canada on the date of grant. The actual exercise price is the Canadian dollar amount regardless of the exchange rate on the date of exercise. |
| 4 | Common | Common Shares | 2022-11-23 | S | D | 2,057 | $34.33 | 23,573 | D | — | — | (F1) The "Amount" and "Price" reported in this Column 4 reflect the aggregate number and weighted-average price, respectively, of shares sold. These shares were sold in multiple transactions at prices ranging from $34.24 to $34.36, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein. |
| 5 | Derivative | Stock Option (Right to Buy) | 2022-11-25 | M | D | 2,057 | $0.00 | 0 | D | $2.68 · — to 2022-12-31 | 2,057 Common Shares | (F2) The exercise price was converted to U.S. dollars from $2.67 CAD using the closing rate of exchange on the Bank of Canada on the date of grant. The actual exercise price is the Canadian dollar amount regardless of the exchange rate on the date of exercise. (F6) The shares subject to the option are fully vested and exercisable. |